Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Vaccination
Vaccination - Credit: Photo: londondeposit/DepositPhoto
Health
Meningococcus
meningococcal bacterium type W
RIVM
vaccination
infection
Hans van Vliet
Wednesday, 10 July 2019 - 15:10

Share this article:

Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window

Netherlands sees slight decrease in Meningococcus W infections

The number of infections with Meningococcus type W bacteria in the Netherlands is declining slightly, according to new figures from public health institute RIVM. The decrease can only partly be attributed by the new vaccination program for this bacteria among teenagers, Hans van Vliet, head of the RIVM's National Vaccination Program, said to NOS.

Meningococcus W is more often fatal than other types of Meningococci bacteria. It can cause blood poisoning and meningitis, which can turn fatal within 24 hours of infection. The RIVM therefore launched a national vaccination program for teenagers between 14 and 18 years last year, as they play a major role in the spread of this bacteria. The vaccination covers four types of Meningococci, including type W.

But according to Van Vliet, the vaccination is likely not the main cause of the decline in infections. "A very small part, but we do not expect the real effect of it until after a longer period of time", he said to NOS. "It seems like a natural development. Just as we could not explain the increase in type W infections since 2015, we can not explain this either."

Before 2015, an average of four people became infected with type W in the Netherlands per year. Last year there were 103 type W infections. Up to and including June this year, 39 type W infections were reported. Since 2015, a total of 45 people in the Netherlands died from a type W infection, 23 of which last year. So far this year, five people have died. The risk of death is particularly high in the age group 14 to 24 years, according to the RIVM.

The decline in infections is reason enough to be cautiously optimistic, Van Vliet said to NOS. "But it is not yet a guarantee. Because the behavior of the bacteria remains difficult to predict", he said. Not much is known about type W yet. "But the entire vaccination campaign is accompanied by all sorts of studies."

More like this

Image
Dutch health agency RIVM
Young adult in the Netherlands dies from measles, health institute confirms
Image
Cropped view of doctor in latex gloves holding syringe and vaccine on blurred foreground near patient
Vaccination rate still falling for older kids, stabilizing for babies and toddlers
Image
A vehicle from the GGD Amsterdam health service in Amsterdam Oost. 8 December 2020
Dutch measles clusters growing fast: Cases exceed all of 2024 in just three months
Image
The girl is sick with measles
Rotterdam organizing extra vaccination rounds against measles to combat outbreak
Make NL Times your top Google source

Follow us:

Latest stories

  • Council of State strongly opposes plan to scrap asylum distribution law
  • Video: Escaped monkey from Beekse Bergen still on the loose after nearly a month
  • Dutch U.S. ambassador sends Venezuelan opposition leader’s plane back during the flight
  • No free water at Arnhem festival where high heat injured five; Water cost over €14/liter
  • Netherlands summons Russian ambassador over Russia's hacking of military supply routes

Top stories

  • Ter Apel asylum center area declared safety risk zone after recent stabbings, fights
  • Suspect in ABN Amro worker's fatal stabbing also harassed four other women
  • New public transport strikes looming as contract talks stall
  • Explosion at apartment complex in Woerden; Dozens of homes evacuated
  • Dutch SMEs investing less due to high costs and inconsistent gov't policy: study

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content